KPTI
Karyopharm Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.35
−11.30%Leverage
- Debt / equity
- -0.65x
- Net debt / equity
- -0.49x
- Debt / assets
- 1.94x
- Debt / EBITDA
- -1.23x
- Net debt / EBITDA
- -0.92x
Liquidity & coverage
- Current ratio
- 0.79x
- Quick ratio
- 0.76x
- Cash ratio
- 0.49x
- Interest coverage
- -1.67x
- EBITDA / interest
- -3.57x
- Working capital
- -$27.9M
Cash & dividend
- FCF / debt
- -0.30x
- Cash flow / debt
- -0.30x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026